VolitionRx Limited (VNRX)
|52 Week Range||0.58-2.74|
|1y Target Est||-|
|DCF Unlevered||VNRX DCF ->|
|DCF Levered||VNRX LDCF ->|
|Debt / Equity||-210.73%||Sell|
Upgrades & Downgrades
Latest VNRX news
VolitionRx Limited (VNRX) Q3 2023 Earnings Call Transcript
15 November 2023
VolitionRx Limited (NYSE:VNRX ) Q3 2023 Earnings Conference Call November 15, 2023 8:30 AM ET Company Participants Scott Powell - Executive Vice President, Investor Relations Cameron Reynolds - Presid...
VolitionRx's Nu.Q Vet Cancer Test sees five-fold revenue surge in 2023
14 November 2023
VolitionRx (NYSE-A:VNRX) said its Nu.Q Vet Cancer Test revenue has seen a nearly five-fold increase in sales over the first nine months of 2023 compared to the same period last year. The Nu.Q test inv...
VolitionRx Limited Schedules Third Quarter 2023 Earnings Conference Call and Business Update
8 November 2023
Conference call to take place on Wednesday November 15 at 8:30 a.m. U.S Eastern Time HENDERSON, Nev.
VolitionRx joins up with VPG to launch Nu.Q Vet Cancer Test in UK and Ireland
6 November 2023
VolitionRx (NYSE-A:VNRX) told investors it has joined forces with Veterinary Pathology Group (VPG) to launch the Nu.Q Vet Cancer Test to veterinary practices in the UK and Ireland. The NuQ Vet Cancer ...
VolitionRx highlights study demonstrating Nu.Q NETs is promising biomarker for septic shock
19 October 2023
VolitionRx (NYSE-A:VNRX) has highlighted a recently published paper in Annals of Intensive Care which shows the company's Nu.Q NETs test is a promising biomarker for the evaluation of disease severity...
VolitionRx welcomes US Ambassador to Belgium for exclusive tour of research facilities
18 October 2023
VolitionRx (NYSE-A:VNRX), the multinational epigenetics company, said it was “delighted” to host Ambassador Michael Adler, the US Ambassador to the Kingdom of Belgium, for an exclusive tour of its sta...
VolitionRx to present cancer detection abstracts at European oncology conference
16 October 2023
VolitionRx (NYSE-A:VNRX) said it will be presenting three scientific abstracts about cancer detection tools at the annual congress of the European Society for Medical Oncology (ESMO) 2023. "We are del...
VolitionRx holds roundtable on sepsis management
13 October 2023
VolitionRx (NYSE-A:VNRX) has revealed insights from a recent Key Opinion Leader (KOL) roundtable focused on sepsis management. The KOL roundtable brought together a panel of leading experts in sepsis ...
VolitionRx to unveil new cancer detection method insights at upcoming webinar
2 October 2023
VolitionRx (NYSE-A:VNRX) Limited has announced that it is participating in a webinar hosted by Edison Group, to expound new cancer data to be presented on October 21 at ESMO 2023, the annual congress ...